ArticleBMC pregnancy and childbirth2026
Association between maternal HBV-DNA levels and pregnancy outcomes among hepatitis B carriers: a retrospective cohort study in China.
Article in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundThe relationship between maternal hepatitis B virus (HBV) DNA load and pregnancy outcomes remains inconsistent. Clarifying this association, including the potential dose-response relationship, is important for improving prenatal management.
methodsA retrospective study was conducted in a single-center cohort of 1,020 HBsAg-positive pregnant women. Participants were categorized by HBV-DNA load, and associations with pregnancy outcomes were assessed using multivariate logistic regression. Sensitivity analyses included multiple imputation for missing data and exclusion of women who received antiviral therapy during pregnancy.
resultsThe mean age was 32.51 ± 4.75 years, and the mean pre-pregnancy BMI was 21.43 ± 3.07 kg/m². Most participants were multiparous (67.65%) and had a gravidity ≥ 2 (77.16%). After full adjustment for covariates, women in the highest HBV-DNA load group (Group 3) had a higher risk of preterm birth than those in the lowest group (Group 1) (Odds ratio (OR): 5.36; 95% Confidence interval (CI): 2.43–11.82; P < 0.001). Median HBV-DNA levels were higher in the preterm birth group than in the non-preterm group. Restricted cubic spline analysis showed a positive association between maternal HBV-DNA load and preterm birth risk.
conclusionsThis study found that high maternal HBV-DNA load was associated with an increased risk of preterm birth. These findings support the potential clinical value of prenatal HBV-DNA quantification in identifying pregnancies at high risk of preterm birth and enabling timely risk stratification and individualized management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.